作者
Ali Bazarbachi, Myriam Labopin, Giorgia Battipaglia, Azedine Djabali, Jakob Passweg, Gerard Socié, Edouard Forcade, Didier Blaise, Patrice Chevallier, Corentin Orvain, Jan J Cornelissen, William Arcese, Sylvain Chantepie, Khowla Hashaishi, Jean El Cheikh, Michael Medinger, Jordi Esteve, Arnon Nagler, Mohamad Mohty
发表日期
2019/9
期刊
Haematologica
卷号
104
期号
9
页码范围
e398
出版商
Ferrata Storti Foundation
简介
The prognosis of acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is generally poor and these patients are referred to allogeneic stem cell transplantation (allo-SCT) in first complete remission (CR). 1 However, long-term survival remains poor because of early relapse and lack of response to further treatment. 2 Furthermore, relapse after allo-SCT has a dismal outcome with a 1-year survival below 20%.
学术搜索中的文章
A Bazarbachi, M Labopin, G Battipaglia, A Djabali… - Haematologica, 2019